Task: Answer the multiple-choice question.
Query: Which drug exhibits a 10.041% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCCSc1nnc(NC(=O)c2sc3nc(-c4cccs4)ccc3c2N)s1
b: Cc1cc(C)n(-c2nc(C)nc(N)n2)n1
Answer: a. CCCSc1nnc(NC(=O)c2sc3nc(-c4cccs4)ccc3c2N)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCSc1nnc(NC(=O)c2sc3nc(-c4cccs4)ccc3c2N)s1
CCCSc1nnc(NC(=O)c2sc3nc(-c4cccs4)ccc3c2N)s1
3-amino-N-(5-propylsulfanyl-1,3,4-thiadiazol-2-yl)-6-thiophen-2-ylthieno[2,3-b]pyridine-2-carboxamide